These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26383162)

  • 1. Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.
    Shakeri R; Malekzadeh R; Nasrollahzadeh D; Pawlita M; Murphy G; Islami F; Sotoudeh M; Michel A; Etemadi A; Waterboer T; Poustchi H; Brennan P; Boffetta P; Dawsey SM; Kamangar F; Abnet CC
    Cancer Res; 2015 Nov; 75(22):4876-83. PubMed ID: 26383162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
    Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
    Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
    J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma.
    Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF
    Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
    J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.
    Ekström AM; Held M; Hansson LE; Engstrand L; Nyrén O
    Gastroenterology; 2001 Oct; 121(4):784-91. PubMed ID: 11606491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Helicobacter pylori highly cytotoxic genotypes and cardia gastric adenocarcinoma linked? Lessons from Iran.
    Bakhti SZ; Latifi-Navid S; Zahri S; Bakhti FS; Hajavi N; Yazdanbod A
    Cancer Biomark; 2017 Dec; 21(1):235-246. PubMed ID: 29036792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis.
    Yao P; Kartsonaki C; Butt J; Jeske R; de Martel C; Plummer M; Guo Y; Clark S; Walters RG; Chen Y; Avery D; Lv J; Yu C; Wang H; Hill M; Peto R; Li L; Waterboer T; Chen Z; Millwood IY; Yang L
    Int J Epidemiol; 2023 Aug; 52(4):1197-1208. PubMed ID: 36913255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia.
    Peek RM; Vaezi MF; Falk GW; Goldblum JR; Perez-Perez GI; Richter JE; Blaser MJ
    Int J Cancer; 1999 Aug; 82(4):520-4. PubMed ID: 10404065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
    Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
    Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: A meta-analysis.
    El Hafa F; Wang T; Ndifor VM; Jin G
    Helicobacter; 2022 Jun; 27(3):e12881. PubMed ID: 35212073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is cardia cancer aetiologically different from distal stomach cancer?
    Peleteiro B; Cavaleiro-Pinto M; Barros R; Barros H; Lunet N
    Eur J Cancer Prev; 2011 Mar; 20(2):96-101. PubMed ID: 21150780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.
    Gao L; Michel A; Weck MN; Arndt V; Pawlita M; Brenner H
    Cancer Res; 2009 Aug; 69(15):6164-70. PubMed ID: 19602590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China.
    Kamangar F; Qiao YL; Blaser MJ; Sun XD; Katki H; Fan JH; Perez-Perez GI; Abnet CC; Zhao P; Mark SD; Taylor PR; Dawsey SM
    Br J Cancer; 2007 Jan; 96(1):172-6. PubMed ID: 17179990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.